Search Results

BioMidwest

Creative Medical Technology Holdings Announces Evolutionary Development of its iPSCelz® Program with the Successful Generation of iPSC Derived Islet Cells that Produce Human Insulin

Creative Medical Technology Holdings, Inc. announced that it has successfully generated human induced pluripotent stem cells -derived Islet Cells that produce human insulin.

June 24, 2024

·

3 min read

Press Releases

Creative Medical Technology Holdings Announces Positive Initial Safety, Tolerability, and Efficacy Data from First Cohort in Phase 1/2 Trial of CELZ-201-DDT for Chronic Back Pain

January 30, 2025

·

3 min read

Policy

Creative Medical Technology Holdings, Inc. Receives FDA Orphan Drug Designation for CELZ-101 in Key Transplantation Therapy

Creative Medical Technology Holdings, Inc. is pleased to announce the successful receipt of Orphan Drug Designation from the U.S. Food and Drug Administration for CELZ-101, ImmCelzTM.

March 6, 2024

·

4 min read

Press Releases

Creative Medical Technology Holdings Announces $1.85 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules

October 24, 2024

·

3 min read

Press Releases

Creative Proteomics Launches Comprehensive Ames Test Service to Enhance Mutagenicity Testing

January 21, 2025

·

1 min read

Creative Biolabs: The Antibody Landscape Is Revolving

As the industry witnesses a surge in demand for innovative antibodies on prevalent research targets, Creative Biolabs is poised to meet and exceed these expectations with their comprehensive suite of services.

June 5, 2024

·

3 min read

BioMidwest

Creative Medical Technology Holdings Provides Corporate Update

Creative Medical Technology Holdings, Inc., a biotechnology company focused on a regenerative approach to immunotherapy, endocrinology, urology, gynecology, and orthopedics, provided an update on recent business activities.

June 12, 2023

·

6 min read

Creative Enzymes Introduces Fermented Calcium Propionate for Superior Food Preservation Solutions

In an exciting development for the food industry, Creative Enzymes has introduced Fermented Calcium Propionate, a cutting-edge ingredient poised to revolutionize food preservation methods.

June 21, 2024

·

2 min read

Drug Development

Creative Medical Technology Holdings (NASDAQ:CELZ) Granted FDA Clearance To Begin Phase 1/2 Clinical Trial Of AlloStem(TM) For Addressing Chronic Lower Back Pain

Creative Medical Technology Holdings, Inc. (NASDAQ:CELZ), a biotechnology company has received clearance from the FDA to conduct a phase 1/2 clinical trial using their innovative StemSpine® treatment known as AlloStem™.

December 20, 2023

·

3 min read

BioMidwest

Creative Medical Technology Announces $2 Million Share Repurchase Program

Creative Medical Technology Holdings, Inc., a biotechnology company focused on a regenerative approach to immunotherapy, endocrinology, urology, gynecology, and orthopedics, announced that its Board of Directors has approved a share repurchase program.

June 12, 2023

·

2 min read